JPS6447389A - Production of active protein - Google Patents

Production of active protein

Info

Publication number
JPS6447389A
JPS6447389A JP63147909A JP14790988A JPS6447389A JP S6447389 A JPS6447389 A JP S6447389A JP 63147909 A JP63147909 A JP 63147909A JP 14790988 A JP14790988 A JP 14790988A JP S6447389 A JPS6447389 A JP S6447389A
Authority
JP
Japan
Prior art keywords
production
host cells
active protein
proteins
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63147909A
Other languages
English (en)
Inventor
Jiyon Patoroni Jiyosefu
Roi Burandon Marukoomu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BANJI AUSTRALIA Pty Ltd
Bunge Australia Pty Ltd
Original Assignee
BANJI AUSTRALIA Pty Ltd
Bunge Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BANJI AUSTRALIA Pty Ltd, Bunge Australia Pty Ltd filed Critical BANJI AUSTRALIA Pty Ltd
Publication of JPS6447389A publication Critical patent/JPS6447389A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP63147909A 1987-06-15 1988-06-15 Production of active protein Pending JPS6447389A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (1)

Publication Number Publication Date
JPS6447389A true JPS6447389A (en) 1989-02-21

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63147909A Pending JPS6447389A (en) 1987-06-15 1988-06-15 Production of active protein

Country Status (14)

Country Link
US (1) US4992531A (ja)
JP (1) JPS6447389A (ja)
KR (1) KR0126767B1 (ja)
CN (1) CN1032425C (ja)
AT (1) ATE114156T1 (ja)
AU (1) AU609824B2 (ja)
CA (1) CA1305284C (ja)
DE (1) DE3852116T2 (ja)
DK (1) DK322188A (ja)
ES (1) ES2065911T3 (ja)
IE (1) IE66334B1 (ja)
NO (1) NO882635L (ja)
NZ (1) NZ225032A (ja)
ZA (1) ZA884212B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0673090A (ja) * 1992-08-31 1994-03-15 Natl Food Res Inst 界面活性剤を用いたタンパク質の新規な精製法
JP2012516314A (ja) * 2009-01-29 2012-07-19 ユニバーシティ オブ ストラスクライド バラスト水処理システム
JP2013534909A (ja) * 2010-05-21 2013-09-09 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッド 両性イオン性試薬

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JP3279362B2 (ja) * 1992-10-05 2002-04-30 井上 聰一 糖尿病判定方法及び糖尿病判定装置
JP3319812B2 (ja) * 1993-04-05 2002-09-03 井上 聰一 リウマチ判定方法及びリウマチ判定装置
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
DE69943205D1 (de) 1998-08-06 2011-03-31 Mountain View Pharmaceuticals Peg-uricase Konjugate und Verwendung davon
ATE367398T1 (de) * 2000-05-16 2007-08-15 Bolder Biotechnology Inc Verfahren zur rückfaltung von proteinen mit freien cysteinresten
WO2004027378A2 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
WO2004042003A2 (en) * 2002-11-01 2004-05-21 Promega Corporation Cell lysis compositions, methods of use, apparatus, and kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
CA2604399A1 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
US9534013B2 (en) * 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
CZ2007700A3 (cs) 2005-04-11 2008-02-27 Savient Pharmaceuticals, Inc. Variantní forma urátoxidázy a její použití
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
EP2778234B1 (en) 2005-05-31 2017-09-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
EP2102355B1 (en) 2006-12-14 2016-03-02 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
US8288559B2 (en) * 2008-08-18 2012-10-16 Promega Corporation Luminogenic compounds and methods to detect cytochrome P450 3A enzymes
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
CN102965317A (zh) * 2012-11-27 2013-03-13 江南大学 一种产牛磺酸菌株的筛选方法及用该菌株发酵法生产牛磺酸
JP6703484B2 (ja) 2014-01-29 2020-06-03 プロメガ コーポレイションPromega Corporation 細胞による取り込み測定のための、標識用試薬としての、キノンでマスクされたプローブ
CN107075544B (zh) * 2014-07-22 2021-01-29 生物辐射实验室股份有限公司 与聚合酶联用的缓冲液

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0673090A (ja) * 1992-08-31 1994-03-15 Natl Food Res Inst 界面活性剤を用いたタンパク質の新規な精製法
JP2012516314A (ja) * 2009-01-29 2012-07-19 ユニバーシティ オブ ストラスクライド バラスト水処理システム
US9469556B2 (en) 2009-01-29 2016-10-18 University Of Strathclyde Ballast water treatment system
JP2013534909A (ja) * 2010-05-21 2013-09-09 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッド 両性イオン性試薬
US9487480B2 (en) 2010-05-21 2016-11-08 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents
US10710962B2 (en) 2010-05-21 2020-07-14 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents

Also Published As

Publication number Publication date
KR0126767B1 (ko) 1997-12-29
CN1032425C (zh) 1996-07-31
DK322188A (da) 1988-12-17
US4992531A (en) 1991-02-12
AU1763288A (en) 1988-12-15
DE3852116D1 (de) 1994-12-22
ES2065911T3 (es) 1995-03-01
ATE114156T1 (de) 1994-12-15
DK322188D0 (da) 1988-06-14
IE881815L (en) 1988-12-15
CN88103725A (zh) 1988-12-28
NO882635D0 (no) 1988-06-15
DE3852116T2 (de) 1995-03-30
CA1305284C (en) 1992-07-14
NO882635L (no) 1988-12-19
ZA884212B (en) 1989-03-29
KR900000380A (ko) 1990-01-30
AU609824B2 (en) 1991-05-09
IE66334B1 (en) 1995-12-27
NZ225032A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
JPS6447389A (en) Production of active protein
AU586897B2 (en) Thrombin preparations
AU6687486A (en) Solubilization of protein aggregates
SE8903777L (sv) Liposome/doxorubicin, komposition och foerfarande
IL91901A0 (en) Production of liposomes with improved stability during drying
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
AU1141288A (en) Production of proteins in active forms
HU9202435D0 (en) Blood factors produced by a recombinant process, method for expressing said bloode factors and recombinant vaccina viruses utilized in said method
GR851065B (ja)
MY103362A (en) Production of proteins in active forms
CA2090701A1 (en) Solubilization of proteins in active forms
EP0315118A3 (en) Dna coding for endothelin and use thereof
MY103305A (en) Productions of proteins in active forms
GR3003950T3 (ja)
IL77152A0 (en) Expression vectors for protein production in e.coli and their production
HU911112D0 (en) Liquid extraction containing active agents of natural origin, and process for the extraction of of the active agents, and cosmetical preparations with possible medicative effect containing such extraction
IT8421028V0 (it) Struttura di macchina agricola, in particolare per trattare argini e simili.